Pyc Therapeutics Ltd has released a press release.
PKD Clinical Trial - Approval to Escalate Dosing
Earlier from Pyc Therapeutics
- Half Yearly Report and Accounts
- Retail Offer Booklet
- Completion of Placement and Institutional Entitlement Offer
- PYC Raising up to $653m to Deliver Human Efficacy Data